Posted on December 10, 202012/10/20
CMED Sets Maximum Prices for Zolgensma, Luxturna, Brazil’s First Gene Therapies
Posted on December 1, 202012/1/20
Spain’s Revalmed-SNS Network to Include Economic Evaluations in Therapeutic Positioning Reports
Posted on November 30, 202011/30/20
Moderna Seeks FDA, EMA Authorization Following mRNA-1273 Analysis Showing Vaccine 94.1% Effective
Posted on November 23, 202011/23/20
President Trump Unveils Rules to Lower U.S. Prescription Drug Prices
Posted on November 19, 202011/19/20
EVERSANA and Healthjump partner to deepen integration of predictive patient services and enhance RWD-based patient outcomes
Posted on November 18, 202011/18/20
BPI Backs Installment Payments, Returning Funds to Health Insurers’ Morbi-RSA Funding Pool
Posted on November 11, 202011/11/20
Netherlands Kicks Off Zolgensma Review for BeNeLuxA
Posted on November 3, 202011/3/20
Switzerland’s FOPH Lowers Prices of 300 Meds, Set to Save 60M Francs
Posted on October 30, 202010/30/20
French MPs Vote for PLFSS Amendments Regarding ATU, RTU Schemes
Posted on October 27, 202010/27/20